Second implantation at Harborview Medical Center in Seattle marks continued progress in the FDA-approved study informed by promising results from the first participant.
CorTec, a pioneer in active implantable medical technologies, has announced the “successful second implantation” of its proprietary Brain-Computer Interface (BCI) system, the Brain Interchange, in an FDA‑approved clinical trial involving stroke patients at Harborview Medical Center, a major site of UW Medicine.
The implantation follows encouraging neurological gains observed in the study’s first participant, whose rehabilitation progress has strengthened confidence in CorTec’s fully implantable platform for stroke recovery.
This represents another key milestone in the joint effort to evaluate CorTec’s fully implantable closed-loop BCI platform, developed and manufactured entirely in Germany, for therapeutic applications in neurological disorders. [Read more…] about German technology company CorTec implants second human with its brain-computer interface